Efficacy and safety of first-line veliparib and carboplatin-paclitaxel in patients with HER2- advanced germline BRCA+ breast cancer: Subgroup analysis of a randomised clinical trial.
暂无分享，去创建一个
H. Wildiers | M. Friedlander | B. Arun | V. Diéras | B. Kaufman | S. Puhalla | K. Bell-McGuinn | D. Maag | J. Ayoub | B. Bach | C. Ratajczak | H. Han | M. G. Kundu